AAL vs CME

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 14, 2026

AAL

43.7
AI Score
VS
AAL Wins

CME

39.6
AI Score

Investment Advisor Scores

AAL

44score
Recommendation
HOLD

CME

40score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric AAL CME Winner
Forward P/E 12.1065 24.3902 AAL
PEG Ratio 0.2245 4.3556 AAL
Revenue Growth 19.3% 13.0% AAL
Earnings Growth -88.2% 16.1% CME
Tradestie Score 43.7/100 39.6/100 AAL
Profit Margin -0.8% 63.5% CME
Beta 1.00 1.00 Tie
AI Recommendation HOLD EXTENDED Tie

Relative Price Performance (Last 90 Days)

AAL 1M: +7.2% · 3M: -8.7% CME 1M: +9.8% · 3M: +18.7%

Current Technical Phase

AAL

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 50.7 · Price: $13.17

CME

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.5% over 20 days), RSI 72

RSI (14): 71.6 · Price: $317.97

Fundamentals Snapshot

Metric AAL CME
Market Cap — —
Forward P/E 14.0 24.0
Trailing P/E — 25.9
Revenue (TTM) — —
Revenue Growth 0.2% 0.1%
Gross Margin 0.2% 1.0%
Operating Margin 0.0% 0.7%
EPS -0.69 12.19
Dividend Yield — 0.02%

Frequently Asked Questions

Based on our detailed analysis, AAL is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.